Skip to main content
Pharmena S.A. logo

Pharmena S.A. — Investor Relations & Filings

Ticker · PHR ISIN · PLPHRMN00011 LEI · 259400RHT936BBKW0955 WAR Manufacturing
Open in API
Filings indexed 649 across all filing types
Latest filing 2016-05-09 AGM Information
Country PL Poland
Listing WAR PHR

About Pharmena S.A.

https://www.pharmena.eu/

Pharmena S.A. is a specialty healthcare company focused on the development and commercialization of innovative products based on its patented active ingredient, 1-MNA. This molecule is a naturally occurring metabolite of niacin (vitamin B3) that plays a crucial role in cellular metabolism. The company's technology leverages the ability of 1-MNA to optimize the levels of the coenzyme NAD+, which decline with age and are vital for cellular function and regeneration. The product portfolio includes specialized cosmeceuticals, such as the Dermena line for hair loss, and dietary supplements designed to address the effects of cellular aging.

Recent filings

Filing Released Lang Actions
PHARMENA Projekty uchwał na ZWZ w dniu 15 06 2016
AGM Information Classification · 99% confidence The document text is titled 'Projekty uchwał Zwyczajnego Walnego Zgromadzenia' (Draft resolutions of the Annual General Meeting) and details numerous resolutions passed by the 'Zwyczajne Walne Zgromadzenie' (Annual General Meeting) on June 15, 2016. These resolutions cover the approval of annual reports (financial and management), dividend distribution, and granting of 'absolutorium' (discharge) to board and supervisory council members for the 2015 fiscal year. This content is characteristic of the formal proceedings and documentation related to an Annual General Meeting.
2016-05-09 Polish
PHARMENA Ogłoszenie o zwołaniu ZWZ w dniu 15 06 2016
AGM Information Classification · 99% confidence The document is titled "Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Spółki..." which translates to "Announcement of the convening of the Ordinary General Meeting of the Company...". The text details the date, time, location, and a detailed agenda (Porządek obrad) for the meeting, including items related to approving annual reports for 2015 and voting on resolutions. This content is characteristic of a formal notice calling for a General Meeting of Shareholders. The closest matching category is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). Since this is the official notice convening the meeting, AGM-R is the most appropriate classification, rather than DEF 14A (Proxy Statement) or DVA (Voting Results).
2016-05-09 Polish
Ogłoszenie o zwołaniu ZWZ w dniu 15 czerwca 2016 r. - Content (PL)
AGM Information Classification · 98% confidence The document text is very short (343 characters) and announces the convening of an Ordinary General Meeting (Zwyczajne Walne Zgromadzenie) scheduled for June 15, 2016, including the agenda projects (projekty uchwał). This content directly relates to the preparation and announcement of an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2016-05-09 Polish
Informacja o transakcjach na instrumentach finansowych Emitenta - Content (PL)
Director's Dealing Classification · 99% confidence The document text explicitly states that the Management Board (Zarząd) of PHARMENA S.A. is reporting the receipt of two notifications ('zawiadomień') regarding transactions involving the company's shares. The content details the type of transaction ('Kupno' - Purchase), the instrument (shares), the date (March 30 and 31, 2016), volume, and price. Crucially, the context involves transactions by a person closely related to a member of the Supervisory Board ('Członek Rady Nadzorczej'). This structure perfectly matches the definition of Director's Dealing or insider transaction reporting, which corresponds to the 'DIRS' filing type code.
2016-04-08 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.